Xtx Topco LTD Natera, Inc. Transaction History

Xtx Topco LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$85.28 - $112.6 $80,163 - $105,844	940 Added 24.07%	4,846 $524,000
Q1 2024 May 13, 2024	BUY	$59.21 - $92.9 $231,274 - $362,867	3,906 New	3,906 $357,000
Q3 2023 Nov 13, 2023	BUY	$43.4 - $62.52 $404,531 - $582,748	9,321 Added 99.31%	18,707 $827,000
Q2 2023 Aug 14, 2023	BUY	$47.08 - $55.16 $441,892 - $517,731	9,386 New	9,386 $456,000
Q1 2022 May 13, 2022	SELL	$30.32 - $91.33 $93,779 - $282,483	-3,093 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$86.26 - $119.0 $266,802 - $368,067	3,093 New	3,093 $289,000
Q2 2021 Aug 12, 2021	SELL	$86.05 - $119.72 $278,974 - $388,132	-3,242 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$91.47 - $124.36 $296,545 - $403,175	3,242 New	3,242 $329,000

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.